ATE50870T1 - Sero-immunologisches verfahren zur in-vivo feststellung der wirksamkeit cytostatischer mittel. - Google Patents

Sero-immunologisches verfahren zur in-vivo feststellung der wirksamkeit cytostatischer mittel.

Info

Publication number
ATE50870T1
ATE50870T1 AT83103752T AT83103752T ATE50870T1 AT E50870 T1 ATE50870 T1 AT E50870T1 AT 83103752 T AT83103752 T AT 83103752T AT 83103752 T AT83103752 T AT 83103752T AT E50870 T1 ATE50870 T1 AT E50870T1
Authority
AT
Austria
Prior art keywords
vivo
sero
potency
determining
cytostatic agents
Prior art date
Application number
AT83103752T
Other languages
English (en)
Inventor
Dezsoe Stefan Dr Bartos
Denis Dr Fitzpatrick
Original Assignee
Bartos Patent Dev Holding
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bartos Patent Dev Holding filed Critical Bartos Patent Dev Holding
Application granted granted Critical
Publication of ATE50870T1 publication Critical patent/ATE50870T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT83103752T 1982-04-21 1983-04-19 Sero-immunologisches verfahren zur in-vivo feststellung der wirksamkeit cytostatischer mittel. ATE50870T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE820942A IE820942L (en) 1982-04-21 1982-04-21 Determining in-viro effectiveness of cytostatic agents
EP83103752A EP0092222B1 (de) 1982-04-21 1983-04-19 Sero-immunologisches Verfahren zur in-vivo Feststellung der Wirksamkeit cytostatischer Mittel

Publications (1)

Publication Number Publication Date
ATE50870T1 true ATE50870T1 (de) 1990-03-15

Family

ID=11020059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83103752T ATE50870T1 (de) 1982-04-21 1983-04-19 Sero-immunologisches verfahren zur in-vivo feststellung der wirksamkeit cytostatischer mittel.

Country Status (6)

Country Link
US (1) US4686194A (de)
EP (1) EP0092222B1 (de)
JP (1) JPS58195154A (de)
AT (1) ATE50870T1 (de)
DE (1) DE3381296D1 (de)
IE (1) IE820942L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US20030165888A1 (en) * 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization
DE2729893A1 (de) * 1977-05-23 1978-11-30 Sol Prof Spiegelman Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens

Also Published As

Publication number Publication date
DE3381296D1 (de) 1990-04-12
EP0092222A3 (en) 1985-09-04
JPS58195154A (ja) 1983-11-14
EP0092222B1 (de) 1990-03-07
US4686194A (en) 1987-08-11
IE820942L (en) 1983-10-21
EP0092222A2 (de) 1983-10-26

Similar Documents

Publication Publication Date Title
DD128170A5 (de) Verfahren zur herstellung von praeparaten mit geregelter wirkstoffabgabe
FI830958A7 (fi) Koostumuksia terapeuttista tai diagnostista käyttöä varten ja terapeuttinen käsittelymenetelmä.
AR228452A1 (es) Medio para comprobar la presencia de enzimas esteroliticas y/o proteoliticas y procedimiento para preparar esteres fenoxiamino acidos
IT1129080B (it) Composizione e cartina di prova per la determinazione colorimetrica dell acido ascorbico
DE10075031I1 (de) Zusammensetzung zur kontrolierten Abgabe eines Wirkstoffs
ES505604A0 (es) Procedimiento para la preparacion de derivados de aminoaci- dos
ATE26115T1 (de) Substituierte 8-phenylxanthine.
BE838642A (fr) Utilisation de perfluoroalcane-sulfonamides et/ou de sels d'ammonium et/ou de cyclimmonium d'acides perfluoroalcane-sulfoniques comme agents de demoulage
BR8204736A (pt) Composicao de po para o corpo e po para o corpo
GB2034465B (en) Method and composition for direct determination of iron in blood serum
FI830959A7 (fi) Koostumuksia terapeuttista tai diagnotista käyttöä varten ja terapeuttinen käsittelymenetelmä.
CH532084A (de) Verfahren zur Herstellung von N-(Dimethylaminomethyliden)-thiol (thiono)- phosphorsäureesterimiden sowie ihre Verwendung als Insektizide und Akarizide
AT348687B (de) In-vitro-verfahren zur blutuntersuchung
BG42677A3 (en) Method for preparing of 6- alpha- methylcorticoides
DE3381296D1 (de) Sero-immunologisches verfahren zur in-vivo feststellung der wirksamkeit cytostatischer mittel.
IT1070223B (it) Composizione di fosforo luminescente e procedimento per la sua preparazione
IT1162463B (it) Procedimento per la preparazione di cefalosporine e composizioni farmaceutiche che le contengono e prodotto ottenuto
IT7950714A0 (it) Ariltrifluoroetanoli procedimento per prepararli e composizioni farmaceutiche che li contengono
PH9853A (en) Compositions for inhibiting mobilization of calcium phosphate in animal tissue and method of use thereof
IT8447751A0 (it) Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
AR219370A1 (es) Procedimiento de preparacion de composiciones farmaceuticas detoxificadas de agentes alquilantes citostaticamente activos
ES542299A0 (es) Procedimiento para la preparacion de 1,3-bis-esteres fosfatoy esteres fosfato ciclico de 9-1,3-dihidroxi-2-propoximetil-guanina
BE836621A (fr) Agents ugnifugeants phosphores utilisables dans la preparation de polyurethanes
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
IT7948023A0 (it) Tieno 3 2-c e 2 3-c-piridine procedimento per prepararle e composizioni terapeutiche che le contengono

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee